298 related articles for article (PubMed ID: 342601)
1. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.
Fernandez HN; Henson PM; Otani A; Hugli TE
J Immunol; 1978 Jan; 120(1):109-15. PubMed ID: 342601
[No Abstract] [Full Text] [Related]
2. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
4. Anaphylatoxins inhibit C2 production.
Lappin D; Damerau B; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
[TBL] [Abstract][Full Text] [Related]
5. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
6. Natural inhibitors of leukotaxis.
Ward PA
Prog Clin Biol Res; 1977; 13():77-81. PubMed ID: 400762
[No Abstract] [Full Text] [Related]
7. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
8. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.
Gerard C; Chenoweth DE; Hugli TE
J Immunol; 1981 Nov; 127(5):1978-82. PubMed ID: 7299121
[No Abstract] [Full Text] [Related]
9. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
Nagata S; Glovsky MM; Kunkel SL
Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
Damerau B; Grünefeld E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
[TBL] [Abstract][Full Text] [Related]
12. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
[TBL] [Abstract][Full Text] [Related]
13. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
Hugli TE
Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
[No Abstract] [Full Text] [Related]
14. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
15. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
16. Anaphylatoxins: possible roles in disease.
Vogt W
Complement; 1986; 3(3):177-88. PubMed ID: 3026724
[TBL] [Abstract][Full Text] [Related]
17. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
Rotllant J; Parra D; Peters R; Boshra H; Sunyer JO
Dev Comp Immunol; 2004 Jun; 28(7-8):815-28. PubMed ID: 15043949
[TBL] [Abstract][Full Text] [Related]
18. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the immune response by anaphylatoxins.
Morgan EL
Complement; 1986; 3(3):128-36. PubMed ID: 3542364
[TBL] [Abstract][Full Text] [Related]
20. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]